"National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling price of 530 medicines, out of 680 NLEM medicines (628 net medicines) that are under the scheduled category of DPCO 2013," said Minister of State for Chemicals and Fertilisers Hansraj Gangaram Ahir in Rajya Sabha.
Out of 530 drugs, above 40% price reduction has happened in case of 126 medicines, while prices of 34 drugs has come down in the range of 35-40%.
Also Read
While the prices of 65 medicines have been reduced in the range of 20-25%, 43 medicines have witnessed the price reduction in the range of 15 to 20%, he added.
Moreover, 57 drugs saw price reduction of 10-15%, price of 50 drugs were reduced in range of 5-10%. In case of 80 medicines the reduction with respect to maximum price was between 0 to 5%, Ahir said.
NPPA mandate is to fix or revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country.
It also monitors prices of decontrolled drugs in order to keep them at reasonable levels.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)